Methyl 2-chloro-4-fluorobenzoate

Catalog No. :
ACPTYD064
CAS No. :
85953-29-3
Molecular Formula :
C8H6ClFO2
Molecular Weight :
188.59

IUPAC Name:methyl 2-chloro-4-fluorobenzoate

Methyl 2-chloro-4-fluorobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$56.00Login to see priceIn stockInquiry
500g98%$263.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-chloro-4-fluorobenzoate
IUPAC Namemethyl 2-chloro-4-fluorobenzoate
MDL No.MFCD00173937
Molecular FormulaC8H6ClFO2
Molecular Weight188.59
SMILESC1=C(C(=CC(=C1)F)Cl)C(OC)=O
InChI KeyYZDLPZNWBRBZMZ-UHFFFAOYSA-N
Synonym1T-1481 | DTXSID30377010 | methyl 2-chloro-4-fluorobenzenecarboxylate | PB10114 | AM20060393 | J-521983 | YZDLPZNWBRBZMZ-UHFFFAOYSA-N | AKOS005063974 | BENZOIC ACID, 2-CHLORO-4-FLUORO-, METHYL ESTER | methyl (2-chloro-4-fluorophenyl)formate | MFCD00173937
CAS No.85953-29-3
PubChem CID2763551

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACPTYD064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACBYFR861 route compound structure diagram
    ACBYFR861855471-43-1 In Stock
  4. Then
  5. ACPTYD064 route product structure diagram
    ACPTYD06485953-29-3 In Stock
Inquiry

2. ACPTYD064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBYFR861 route compound structure diagram
    ACBYFR861855471-43-1 In Stock
  6. Then
  7. ACPTYD064 route product structure diagram
    ACPTYD06485953-29-3 In Stock
Inquiry

Comments (0)